Viewing StudyNCT06422520



Ignite Creation Date: 2024-06-16 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06422520
Status: RECRUITING
Last Update Posted: 2024-05-21
First Post: 2024-05-15

Brief Title: A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors
Sponsor: BeiGene
Organization: BeiGene

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-06-24
Start Date Type: ESTIMATED
Primary Completion Date: 2026-11-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-11-30
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-15
First Submit QC Date: May 15 2024
Study First Post Date: 2024-05-21
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-21
Last Update Post Date: 2024-05-21
Last Update Post Date Type: ACTUAL